NEW YORK, Dec. 3 — Gene Prot and Waters announced Monday an agreement to equip GeneProt’s new industrial-scale proteomics facility.

Waters, through its subsidiary Micromass UK, will buy a maximum of $10 million of equity securities in GeneProt. The proteomics company will in turn purchase from Micromass about $20 million in mass spectrometry machines and services. The two companies will also collaborate on product development for these instruments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.